top of page

cover image dna.jpg

R&D PROJECTS

Our scientific activities are co-financed from public funds to support research and development.

Current projects

Study of the efficacy functions of experimental vaccines against coronavirus infections in animal models

CLEMON - Intelligent monitoring of clean rooms for pharmaceutical production

Development of medicinal products DUOFAG® and TRIOFAG® based on safe and effective bacteriophages

Combined phage therapy for supporting the treatment of chronic respiratory diseases

AMBRA - Automated system for microbiological reactions and processes

Innovation of Phage Lysates Through Advanced Lyophilization

Finished projects

Alternative Products and Dermal Cosmetics Research Center (AMI)

Collagenase for Langerhans Islets Isolation

Introduction of a purification step during production
phage lysates

Encapsulation of phages into nanostructures and their use in the production of special filters and antibacterial protection

Development of new methods for monitoring the biological activity of bacterial and bacteriophage lysates (BIO)

Biotechnologically modified collagenase for the preparation of modern therapy products

Medical device certification
Collagenase MB

Development of new phage endolysin-based drugs against the causative agent of Fetal Bee Plague (AFB).

Development of new bacteriophage-based drugs for diseases of fish, bees and mammary glands in cattle

Project for the protection of industrial property rights

Development of a cosmetic product containing bacteriophages to maintain natural skin microflora (KOSMOFAG)

Development of a cosmetic product containing bacteriophages to maintain natural skin microflora (KOSMOFAG)

bottom of page